Yes it would seem a CR is more likely required than not and may explain the recent pullback in SP despite all the great information released recently. I’m optimistic that SI has some good options (would be great if the SurgCentre folk wanted to average down prior to the CLBP RCT). Leaving the CHF partnership decisions post FDA feedback.
- Forums
- ASX - By Stock
- Ann: Mesoblast Second Quarter Financial Results Webcast
Yes it would seem a CR is more likely required than not and may...
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.11 |
Change
0.010(0.91%) |
Mkt cap ! $1.261B |
Open | High | Low | Value | Volume |
$1.09 | $1.11 | $1.07 | $4.794M | 4.399M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 14500 | $1.10 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.11 | 141676 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 14500 | 1.100 |
2 | 93112 | 1.095 |
2 | 37684 | 1.090 |
3 | 40400 | 1.085 |
2 | 61100 | 1.080 |
Price($) | Vol. | No. |
---|---|---|
1.110 | 141676 | 5 |
1.115 | 41050 | 3 |
1.120 | 157964 | 9 |
1.125 | 61233 | 3 |
1.130 | 111595 | 5 |
Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |